1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
19 
risk to health and the environment presented by 
recombinant DNA research ; and 
(D) federally sponsored basic and applied 
recombinant DNA research ; and 
(2) conduct a. study of the long-term consequences 
of the development of a technology capable of accom- 
plishing the genetic modification of organisms and viruses 
and include in siich study— 
(A) an evaluation of the anticipated applica- 
tions of genetic manipulation technology to siich 
area's as medicine, pharmacology, immunology, in- 
dustrial fermentation, and agriculture ; ahd 
(B) a thorough consideration of the ethical, 
moral, social, economic^ and political implications of 
the development and use of such technology. 
Sec. 203. (a) The Commission shall in carrying out 
its duties under section 202 hold public hearings as ap- 
propriate. 
(b) The Commission may secure directly from any 
department or agency of the United States information neces- 
sary to enable it to carry out its duties. Upon the request of 
the Chairman of the Commission, the head of such depart- 
ment or agency shall furnish such information to the Com- 
mission. 
[Appendix B — 21] 
